Pooled Dosing and Efficacy Analysis of the Sufentanil Sublingual Tablet 30 mcg Across Demographic Subgroups for the Management of Moderate-to-Severe Acute Pain

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 01, 2020
Source ID
10.1016/j.jopan.2019.08.009

Entities

People

  • David Leiman
  • Jacob L. Hutchins
  • Karen P. Didonato
  • Pamela Pierce Palmer
  • Zubaid Rafique

Organizations

  • AcelRx Pharmaceuticals (United States)
  • United States Army Medical Research and Development Command